Pharmacology of enalapril in children: a review
Open Access
- 1 November 2020
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 25 (11) , 1957-1970
Abstract
No abstract availableKeywords
Funding Information
- Seventh Framework Programme
- Seventh Framework Programme (602295)
This publication has 131 references indexed in Scilit:
- Renin-Angiotensin-Aldosterone Genotype Influences Ventricular Remodeling in Infants With Single VentricleCirculation, 2011
- Lessons learned from a pediatric clinical trial: The Pediatric Heart Network Angiotensin-Converting Enzyme Inhibition in Mitral Regurgitation StudyAmerican Heart Journal, 2011
- Enalapril in Infants With Single VentricleCirculation, 2010
- Association of Proteinuria with Race, Cause of Chronic Kidney Disease, and Glomerular Filtration Rate in the Chronic Kidney Disease in Children StudyClinical Journal of the American Society of Nephrology, 2009
- Human carboxylesterases HCE1 and HCE2: Ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrinBiochemical Pharmacology, 2009
- Racial Differences in Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitors in Children: A Meta-AnalysisClinical Pharmacology & Therapeutics, 2008
- Use of enalaprilat for neonatal hypertensionThe Journal of Pediatrics, 1991
- Orally administered enalapril for infants with congestive heart failure: A dose-finding studyThe Journal of Pediatrics, 1989
- Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal diseaseThe Journal of Pediatrics, 1988
- Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.Circulation, 1981